BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 10.05.2016

Clinical Trial Design Considerations for Malaria Drug Development Media; Public Workshop

The Food and Drug Administration (FDA) is announcing a public workshop regarding clinical trial design considerations for malaria drug development. FDA is interested in discussing the scientific challenges pertaining to malaria drug development and malaria parasite detection methods used as endpoints in clinical trials. This public workshop is intended to provide information for and gain perspective from health care providers, other U.S. government agencies, public health organizations, academic experts, and industry on various aspects of the design of clinical trials evaluating new drugs to treat malaria. The input from this public workshop will also help in developing topics for future discussion. Dates and Times: The public workshop will be held on June 30, 2016, from 8:30 a.m. to 4 p.m. Location: The public workshop will be held at FDA's White Oak campus, 10903 New Hampshire Ave., Bldg. 31 Great Rm., Silver Spring, MD 20993. Entrance for the public workshop participants (non-FDA employees) is through Building 1 where routine security check procedures will be performed. For parking and security information, please refer to http://www.fda.gov/AboutFDA/WorkingatFDA/ BuildingsandFa

Source: Federal Register — Food and Drug AdministrationOpen original release →